IBM’s Watson Will Use AI To Treat Cancer

IBM's Watson artificial intelligence platform has joined forces with researchers at MIT and Harvard to study how thousands of cancers mutate to become resistant to drug treatments that initially worked to beat back the disease.

By discovering how cancers adapt to overcome drug therapies, researchers at MIT's and Harvard's Broad Institute genomics research center hope to develop a new generation of therapies that cancers cannot circumvent.

While a growing number of treatments can hold cancers in check for months or years, most cancers eventually recur, according to the Broad Institute researchers. This is in part because tumors acquire mutations that make them drug resistant.

That cancer drug resistance is a major cause of nearly 600,000 annual deaths in the US alone, according to Eric Lander, the founding director of the Broad Institute. While scientists have discovered the cause of drug resistance in a small number of cancer cases, which has led to the development of new, successful treatments, most cases are not fully understood.

The new five-year, $50 million genome project will study thousands of drug resistant tumors and draw on Watson's computational and machine learning methods to help researchers understand how cancers become resistant to therapies.

"Defeating cancer involves playing a high-stakes game of biological chess. When we make a move with a therapy, cancer often responds with a counter-move by finding a way to become resistant. The key will be learning from clinical experience, so that we know cancer's moves in advance and can plan strategies to cut off its escape routes," Lander said.

To help understand how cancers become resistant to specific therapies, the Broad Institute will generate tumor genome sequence data from patients who initially respond to treatment but whose cancers then become drug-resistant. 

The Broad Institute will use new genome-editing methods to conduct large-scale cancer drug resistance studies in the laboratory, to help identify tumors' specific vulnerabilities. IBM scientists will use Watson to analyze this data and identify genomic patterns that may help researchers and clinicians predict drug sensitivity and resistance.

Recently, IBM and Quest Diagnostics launched IBM Watson Genomics, a service available to US oncologists to help advance personalized medicine by combining cognitive computing with genomic tumor sequencing. The service marked the first time that Watson for Genomics was made widely available to patients and physicians across the country.

The collaboration with the Broad Institute has recently been announced is the latest application of Watson for Genomics to help researchers and clinicians tackle the challenges and opportunities of cancer genomics.

Watson for Genomics will sift through anonymised patient data that will be made available to the scientific community to catalyze research worldwide, and uncover hidden patterns that could help scientists better understand the molecular underpinnings behind cancer treatment resistance.

"The Broad Institute is leading the industry in areas of cancer biology, genomics and computational biology, and we are proud to bring Watson's data prowess to help researchers learn more about one of most important medical challenges that too often stands in the way of effective cancer treatment," John Kelly III, IBM Research's senior vice president of Cognitive Solutions, said in a statement. "Our hope is that this effort, if successful, could eventually lead to significant breakthroughs. Someday, patients who would not otherwise have options in their battle against cancer may have reason for hope."

Computerworld:        IBM’s Watson Takes Aim At CyberSecurity:
 

 

« Australia Goes To Cyberwar With Islamic State
Google Launches New Weapon Against Islamic State »

ManageEngine
CyberSecurity Jobsite
Check Point

Directory of Suppliers

Authentic8

Authentic8

Authentic8 transforms how organizations secure and control the use of the web with Silo, its patented cloud browser.

ZenGRC

ZenGRC

ZenGRC (formerly Reciprocity) is a leader in the GRC SaaS landscape, offering robust and intuitive products designed to make compliance straightforward and efficient.

North Infosec Testing (North IT)

North Infosec Testing (North IT)

North IT (North Infosec Testing) are an award-winning provider of web, software, and application penetration testing.

Jooble

Jooble

Jooble is a job search aggregator operating in 71 countries worldwide. We simplify the job search process by displaying active job ads from major job boards and career sites across the internet.

Clayden Law

Clayden Law

Clayden Law advise global businesses that buy and sell technology products and services. We are experts in information technology, data privacy and cybersecurity law.

Acuity RM Group

Acuity RM Group

Acuity RM Group helps businesses worldwide effectively manage, prioritize and report on their risks to inform strategic and tactical decision-making and build long-term resilience.

Concise Technologies

Concise Technologies

Concise Technologies provide specialist IT and telecoms solutions, support services, managed backup, disaster recovery, cyber security and consultancy to SME businesses across the UK and Europe.

Authorize.Net

Authorize.Net

Authorize.Net is a Payment Gateway which provides the complex infrastructure and security necessary to ensure fast, reliable and secure transactions.

Pole SCS (Secure Communicating Solutions)

Pole SCS (Secure Communicating Solutions)

SCS is a world-class competitiveness cluster dedicated to digital technologies in the fields of Microelectronics, Internet Of Things, Digital Security, Artificial Intelligence And Big Data.

Security & Intelligence Agency (SOA) - Croatia

Security & Intelligence Agency (SOA) - Croatia

SOA is the Croatian security and intelligence service. Areas of activity include Cyber Security and Information Security.

Balbix

Balbix

Balbix BreachControl™ is the industry’s first system to leverage specialized AI to provide comprehensive and continuous predictive assessment of breach risk.

Penten

Penten

Penten is an Australian-based cyber security company focused on innovation in secure mobility and applied AI (artificial intelligence).

TestArmy

TestArmy

TestArmy CyberForces provide you with a broad spectrum of cybersecurity services to test every aspect of your IT infrastructure security and software development process.

Zephyr Project

Zephyr Project

The Zephyr Project strives to deliver the best-in-class RTOS for connected resource-constrained devices, built to be secure and safe.

StickmanCyber

StickmanCyber

At StickmanCyber we are on a mission to create a digital world that is safe for everyone - we are your trusted cybersecurity partner.

Centroid

Centroid

Centroid is a cloud services and technology company that provides Oracle enterprise workload consulting and managed services across Oracle, Azure, Amazon, Google, and private cloud.

NetGain Technologies

NetGain Technologies

NetGain Technologies helps small to medium-sized businesses gain access to expert IT talent. We provide strategies that use technology as a driving force behind business growth.

SIGLA Group

SIGLA Group

SIGLA Group specialize in the design and development of IT and OT solutions, from analysis to design, from implementation to commissioning, as well as consultancy, training and assistance.

INT3L

INT3L

The INT3L group (formerly Defentek) is a provider of national security and intelligence solutions, systems and services.

Crisis24

Crisis24

Crisis24 is a leading integrated risk management, crisis response, consulting, and global protective solutions firm.

Garantir

Garantir

Garantir is a cybersecurity company that provides advanced cryptographic solutions to the enterprise.